GVR Report cover Immunoinformatics Market Size, Share & Trends Report

Immunoinformatics Market Size, Share & Trends Analysis Report By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2025

  • Historical Data: ---
  • Forecast Period: 1 - 2025 
  • Industry: Healthcare

The global immunoinformatics market is expected to witness lucrative growth owing to numerous applications with integration of computational and experimental approaches in handling abundant genome sequencing data of humans and organisms. Furthermore, advancements pertaining to R&D activities are expected to upsurge market growth that include host pathogen interaction in diseases diagnosis and allergy prediction.

Additionally, research areas such as design and engineering of immune therapeutics & diagnostics, immunomic database design, immune system response modeling & stimulation of laboratory experiments, and in-silico vaccination are expected to widen the scope of research activities in the immunoinformatics market

In addition, developments in proteomics and genomics are expected to reinforce market growth over the forecast period. Integration of immunoinformatics with systems biology pertaining to the development of personalized medicine is anticipated to witness significant gains in the coming seven years.

Incremental developments as a result of high throughput molecular biology techniques and effect of drug administration through computational methods enable the market to grow at an accelerated pace over the forecast period.

Substantial improvements in the field of immunoinformatics with coordination of efforts by immunologists and bioinformaticians to establish an integrated platform are poised to heighten market growth over the forecast period. Furthermore, growing advent of new technology in the field of immunoproteomics and immunogenomics is one of the critical success factors attributing to immunoinformatics market growth.

Increasing prevalence of tropical and emerging infectious diseases and rising concerns targeting key determinants of the immunity system through systematic immunoinformatics-driven approach are expected to drive the market over the forecast period.

Increasing funding pertaining to rapid development of novel vaccines through collaborations between academic and industry organizations such as the Vaccine and Immunotherapy Center and the Defense Threat Reduction Industry, will help in progressing the field of immunoinformatics.

The global immunoinformatics market is segmented on the basis of application and database types. Furthermore, immunoinformatics finds its application in reverse vaccinology, cancer diagnosis & therapy, and immune system modeling.

The types of databases analyzed in this field include the international immunogenetics system, immune epitope database and analysis resource database, ontology of immune epitopes, and allergy prediction databases.

High success rate achieved through prediction from machine learning technologies that include artificial neural network and support vector machine, and also error-free robust results will positively reinforce market growth.

North America, Asia Pacific, Europe, MEA, and Latin America are the key regions of immunoinformatics market. In 2014, North America emerged as one of the largest markets owing to the presence of critical success factors such as sophisticated infrastructure pertaining to rigorous R&D procedures accomplished by collaborations between clinicians and scientists.

Additionally, rising incidences of chronic diseases and growing demand for cost-effective and accurate vaccines to effectively curb these diseases are expected to drive market growth.

Furthermore, growing number of sponsorships by the U.S. National Institutes of Health encouraging fundamental research for vaccine development is anticipated to promote immunoinformatics market growth.

Additionally, productive collaborations between research organizations and major players facilitating research activities and addressing the prevalence of non-commercial diseases are expected to upsurge the immunoinformatics market demand. For example, successful collaboration between pharmaceutical companies and the IMGT to develop novel products for infectious diseases.

Additionally, the Department of Defense (DOD) and the NIH, which are highly interested in vaccine-related research are currently funding projects in vaccines for biodefense and neglected tropical diseases.

For example, iCubed is currently in collaboration with NIH for research in translational vaccine design for emerging infectious diseases.

However, Asia Pacific is expected to lead as the fastest growing regional segment owing to improving infrastructure facilities for research activities.

In addition, favorable government initiatives triggering the need for research activities for novel therapeutics and improving production processes to effectively curb with the increasing prevalence of various diseases such as diabetes, cancer, and HIV are expected to drive market growth.

Major players operating in the immunoinformatics industry include EpiVax Inc., Novozymes Biopharma, ioGenetics LLC, International Society of Vaccines, and IMGT. Constant R&D activities and modifications in engineering the molecular processes pertaining to deliver more accurate and high-performance results are some of the strategic initiatives implemented by these players.

Collaborations between these players that address the needs of current technology in research activities are anticipated to heighten demand for novel therapeutics and vaccines.

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.